[go: up one dir, main page]

MX2021005119A - Formulacion aerosolizada. - Google Patents

Formulacion aerosolizada.

Info

Publication number
MX2021005119A
MX2021005119A MX2021005119A MX2021005119A MX2021005119A MX 2021005119 A MX2021005119 A MX 2021005119A MX 2021005119 A MX2021005119 A MX 2021005119A MX 2021005119 A MX2021005119 A MX 2021005119A MX 2021005119 A MX2021005119 A MX 2021005119A
Authority
MX
Mexico
Prior art keywords
aerosolised formulation
aerosolised
formulation
6âμm
aerosol
Prior art date
Application number
MX2021005119A
Other languages
English (en)
Inventor
Ross Cabot
Original Assignee
Nicoventures Trading Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicoventures Trading Ltd filed Critical Nicoventures Trading Ltd
Publication of MX2021005119A publication Critical patent/MX2021005119A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241—Extraction of specific substances
    • A24B15/243—Nicotine
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/301—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by aromatic compounds
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/32—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by acyclic compounds
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/34—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a carbocyclic ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/40—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms
    • A24B15/403—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms
    • A24B15/406—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms in a five-membered ring
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/10—Devices using liquid inhalable precursors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B06—GENERATING OR TRANSMITTING MECHANICAL VIBRATIONS IN GENERAL
    • B06B—METHODS OR APPARATUS FOR GENERATING OR TRANSMITTING MECHANICAL VIBRATIONS OF INFRASONIC, SONIC, OR ULTRASONIC FREQUENCY, e.g. FOR PERFORMING MECHANICAL WORK IN GENERAL
    • B06B1/00—Methods or apparatus for generating mechanical vibrations of infrasonic, sonic, or ultrasonic frequency
    • B06B1/20—Methods or apparatus for generating mechanical vibrations of infrasonic, sonic, or ultrasonic frequency making use of a vibrating fluid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Manufacture Of Tobacco Products (AREA)

Abstract

Se proporciona una formulación aerosolizada contenida que comprende (i) agua en una cantidad de al menos 50% en peso con base en la formulación aerosolizada; y (ii) al menos un agente activo; en donde el aerosol tiene la siguiente distribución de tamaño de partícula: D50 de 2 a 6µm.
MX2021005119A 2018-11-01 2019-10-31 Formulacion aerosolizada. MX2021005119A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1817868.1A GB201817868D0 (en) 2018-11-01 2018-11-01 Aerosolised formulation
PCT/GB2019/053093 WO2020089638A1 (en) 2018-11-01 2019-10-31 Aerosolised formulation

Publications (1)

Publication Number Publication Date
MX2021005119A true MX2021005119A (es) 2021-06-15

Family

ID=64655395

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021005119A MX2021005119A (es) 2018-11-01 2019-10-31 Formulacion aerosolizada.

Country Status (14)

Country Link
US (1) US20230180818A1 (es)
EP (1) EP3873246A1 (es)
JP (2) JP2022506076A (es)
KR (1) KR102684661B1 (es)
CN (1) CN113163840A (es)
AU (1) AU2019372223B2 (es)
BR (1) BR112021008551A2 (es)
CA (1) CA3118055A1 (es)
GB (1) GB201817868D0 (es)
IL (1) IL282585B2 (es)
MX (1) MX2021005119A (es)
RU (1) RU2764202C1 (es)
UA (1) UA127932C2 (es)
WO (1) WO2020089638A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201817860D0 (en) 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolised formulation
GB201817863D0 (en) 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB202011092D0 (en) * 2020-07-17 2020-09-02 Nicoventures Trading Ltd Consumable
US11771132B2 (en) 2020-08-27 2023-10-03 Rai Strategic Holdings, Inc. Atomization nozzle for aerosol delivery device
GB202013489D0 (en) 2020-08-27 2020-10-14 Nicoventures Holdings Ltd Consumable
US11771136B2 (en) 2020-09-28 2023-10-03 Rai Strategic Holdings, Inc. Aerosol delivery device

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945928A (en) * 1986-03-17 1990-08-07 Rose Jed E Smoking of regenerated tobacco smoke
IN172374B (es) * 1988-05-16 1993-07-10 Reynolds Tobacco Co R
US5144964A (en) * 1991-03-14 1992-09-08 Philip Morris Incorporated Smoking compositions containing a flavorant-release additive
ATE214575T1 (de) * 1993-06-29 2002-04-15 Ponwell Entpr Ltd Spender
KR20010101991A (ko) * 1999-02-03 2001-11-15 간덴 데, 죠스트 에. 리포좀 분말 에어로졸의 폐적용을 위한 압축 공기 흡입기및 그에 적합한 분말 에어로졸
US20080138399A1 (en) * 1999-07-16 2008-06-12 Aradigm Corporation Dual release nicotine formulations, and systems and methods for their use
US6805853B2 (en) * 2001-11-09 2004-10-19 Alexza Molecular Delivery Corporation Delivery of diazepam through an inhalation route
CA2538237A1 (en) * 2003-09-10 2005-03-24 Map Pharmaceuticals, Inc. Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
GB0918129D0 (en) * 2009-10-16 2009-12-02 British American Tobacco Co Control of puff profile
US10667553B2 (en) * 2013-01-24 2020-06-02 Fontem Holdings 4 B.V. Method, composition and apparatus for functionalization of aerosols from non combustible smoking articles
TWI697288B (zh) * 2013-05-21 2020-07-01 瑞士商菲利浦莫里斯製品股份有限公司 匣體、構成為容納匣體的裝置、氣溶膠分送系統、分送氣溶膠化之含藥劑粒子給使用者的方法
US11202470B2 (en) * 2013-05-22 2021-12-21 Njoy, Inc. Compositions, devices, and methods for nicotine aerosol delivery
US20150013695A1 (en) * 2013-07-10 2015-01-15 Ahkeo Ventures LLC Inhalable compositions comprising caffeine, methods of use and an apparatus for using the same
EP3838316B1 (en) * 2013-07-11 2024-04-03 Alexza Pharmaceuticals, Inc. Drug delivery and drug cessation system
EP4552512A3 (en) * 2013-12-05 2025-07-02 Juul Labs, Inc. Nicotine liquid formulations for aerosol devices and methods thereof
TWI664918B (zh) * 2014-05-21 2019-07-11 瑞士商菲利浦莫里斯製品股份有限公司 可感應加熱的菸草產品
GB201413835D0 (en) * 2014-08-05 2014-09-17 Nicoventures Holdings Ltd Electronic vapour provision system
GB2535427A (en) * 2014-11-07 2016-08-24 Nicoventures Holdings Ltd Solution
US20160198759A1 (en) * 2015-01-13 2016-07-14 Zip Llc E-cigarette or vaping fluid
CA2974364C (en) * 2015-01-22 2020-10-27 Fontem Holdings 1 B.V. Electronic vaporization devices
US9585835B1 (en) * 2015-09-16 2017-03-07 Sansa Corporation (Barbados) Inc. Inhalable nicotine formulations and methods of making and using the same
US20170303580A1 (en) * 2016-04-25 2017-10-26 Lunatech, Llc Natural-based liquid composition and electronic vaporizing devices for using such composition
DE102015117811A1 (de) * 2015-10-20 2017-04-20 Chv Pharma Gmbh & Co. Kg Inhalator sowie wirkstoffhaltige Zubereitung für einen Inhalator
WO2017149534A1 (en) * 2016-02-29 2017-09-08 Nicogen Ltd. Nicotine formulation and aerosols
US12501928B2 (en) * 2016-03-11 2025-12-23 Altria Client Services Llc Multiple dispersion generating e-vaping device having a dual piston cylinder, configured to reduce a transmission of a pressure force from a carbon dioxide capsule to a tank configured to store a pre-aerosol formulation
US20170325494A1 (en) * 2016-05-16 2017-11-16 Lunatech, Llc Liquid composition containing nicotine from non-tobacco source for use with electronic vaporizing devices
EP3527085A4 (en) * 2016-10-12 2020-06-03 Japan Tobacco Inc. TASTE INHALATOR
EP3574902A1 (en) * 2018-06-01 2019-12-04 Yatzz Limited Nicotine formulation and mode of delivery

Also Published As

Publication number Publication date
JP2022506076A (ja) 2022-01-17
BR112021008551A2 (pt) 2021-08-03
JP2023120433A (ja) 2023-08-29
KR20210080403A (ko) 2021-06-30
UA127932C2 (uk) 2024-02-14
US20230180818A1 (en) 2023-06-15
IL282585B2 (en) 2024-06-01
CN113163840A (zh) 2021-07-23
GB201817868D0 (en) 2018-12-19
AU2019372223A1 (en) 2021-05-27
AU2019372223B2 (en) 2022-07-14
RU2764202C1 (ru) 2022-01-14
EP3873246A1 (en) 2021-09-08
KR102684661B1 (ko) 2024-07-11
NZ775338A (en) 2024-09-27
IL282585B1 (en) 2024-02-01
WO2020089638A1 (en) 2020-05-07
CA3118055A1 (en) 2020-05-07
IL282585A (en) 2021-06-30

Similar Documents

Publication Publication Date Title
MX2021005119A (es) Formulacion aerosolizada.
ZA202006025B (en) Cryoprotective agents for particulate formulations
MY206012A (en) Aerosolisable formulation
MX2021007416A (es) Composiciones de agente espumante que contienen 1,2,2-trifluoro-1-trifluorometilciclobutano y metodos de espumado.
WO2019222112A8 (en) Mcl-1 inhibitors
MX2020013557A (es) Un esteroide de c21-pirazolilo disustituido con 19-nor c3,3 y métodos de uso del mismo.
CL2020002252A1 (es) Formulación oftálmica.
MX2020007356A (es) Capsula de producto de higiene y sus metodos de uso.
MX2021005164A (es) Formulacion aerosolizable.
MX2023006856A (es) Composiciones de polvo seco con estearato de magnesio.
MY203193A (en) Aerosolisable formulation
EP2571486A4 (en) DRY POWDER INHALATION COMPOSITION
MY197901A (en) Composition containing camellia sinensis extract
PH12017501351B1 (en) Encapsulation of high potency active agents
EP4353091A3 (en) Aerosolisable formulation
MY188643A (en) Cosmetic
MX2021005120A (es) Formulacion aerosolizada.
WO2021046315A3 (en) Inhibitors of encephalitic alphaviruses
PH12020550232B1 (en) Pesticide composition containing thidiazuron and polyglutamic acid
EP4470621A3 (en) Use of sodium alkyl sulfate
MY210136A (en) Insecticidal formulation for vector and pest control with increased contact efficacy
MX2017000454A (es) Composiciones bucales antisarro.
SA521420975B1 (ar) صيغ ذات تركيبة نانوية لتوصيل سيليبينين وعناصر نشطة أخرى لعلاج أمراض العين
SG11201808241WA (en) Composition for skin moisturization or skin whitening, containing pentacyclic triterpene caffeic acid esters
PH12021551433A1 (en) Insecticidal formulation for vector and pest control with increased contact efficacy